For two decades, the laboratory mouse has been the workhorse of biomedical studies and the only mammal whose genes scientists could effectively and reliably manipulate to study human diseases and conditions. Now researchers at UT Southwestern Medical Center have added another experimental research animal to the scientific stable: the rat…
Lees meer..
National Institute of Health grant expands OHSU’s 15-year research effort into the cause, prevention, treatment of the disease Oregon Health & Science University is partnering with the University of Oregon and Harvard Medical School to expedite basic science research into new and existing drugs and compounds that may prevent the complications associated with Fanconi anemia, …
Lees meer..
SATURDAY, May 29 — About 6,000 Americans under the age of 14 are hospitalized each year because of a diving injury, and 20 percent of diving accidents result in a severe spinal cord injury, researchers say.
To encourage diver safety, University of…
SATURDAY, May 29 — A national push to encourage seat belt use in the United States is being launched by the Governor’s Highway Safety Association and the National Highway Traffic Safety Administration.
Known as “Click It or Ticket,” the campaign…
The World Health Organization (WHO) has described the trends in some countries as “extremely worrisome” and asks governments to ban all tobacco advertising, promotion and sponsorship, and to eliminate tobacco smoke from all public and work places. WHO Director-General Dr Margaret Chan said that tobacco use is “neither liberating nor glamorous..it is addictive and deadly”…
Lees meer..
Doncaster and Bassetlaw Hospitals NHS Foundation Trust is upgrading its breast imaging services with the installation of six Full Field Digital Mammography systems from Siemens Healthcare. Two MAMMOMAT Inspiration™ units have already been installed in the Jasmine Suite at Doncaster Royal Infirmary and are currently being used in the examination of symptomatic patients…
Lees meer..
VIVUS, Inc. (Nasdaq: VVUS) announced that phase 3 data on avanafil, a next generation oral phosphodiesterase type 5 (PDE5) inhibitor therapy being investigated for the treatment of erectile dysfunction (ED), will be presented next Tuesday at the American Urological Association (AUA) 2010 Annual Meeting in San Francisco, California. Irwin Goldstein, M.D…
Lees meer..
Repligen Corporation (Nasdaq: RGEN) announced that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company’s proposal to re-analyze the images from our Phase 3 study to establish the utility of RG1068, synthetic human secretin, in improving magnetic resonance imaging (MRI) of the pancreas (Phase 3 re-read)…
Lees meer..
Tengion Inc. (Nasdaq: TNGN) announced that its scientists have presented new research data in three podium presentations at the 16th Annual Meeting of the International Society for Cellular Therapy (ISCT) which was held May 23-26 in Philadelphia…
Lees meer..
VIVUS, Inc. (Nasdaq: VVUS) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company’s new drug application (NDA) for its investigational drug, Qnexa®, for the treatment of obesity. The target date for the FDA to complete its review of the Qnexa NDA is October 28, 2010…
Lees meer..